← Eichor
Condition: Cancer Associated Thrombosis Cat Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cancer Associated Thrombosis Cat

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06386107Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06714734Statins to Prevent Cancer Associated Blood Clots
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT07303816REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.